Hiraku Murakami1, Hideki Mitsui1, Tsuyoshi Kamae1, Jun Ishikawa2, Hitoshi Yoshida2, Masashi Nakagawa3, Hiroyuki Sugahara4, Hirokazu Ikeda5, Manabu Kawakami6, Norimitsu Saitoh1 (1.JAPAN, 2.Osaka International Cancer Institute, 3.Osaka General Medical Center., 4.Sumitomo Hospital, 5.National Hospital Organization Osaka National Hospital, 6.Nissay Hospital)
Session information
Oral Session
Oral Session 3-12A CML: Clinical
Sun. Oct 14, 2018 8:30 AM - 9:30 AM No.12 (Osaka International Convention Center, 10F 1006-7)
Chair: Kaichi Nishiwaki (Division of Oncology and Hematology, Jikei University Kashiwa Hospital, Japan)
Takatoshi Aoki, Daisuke Ishihara, Shingo Urata, Tomohiko Kamimura (Hematology., Harasanshin Hospital., Fukuoka, Japan)
Koichi Miyamura1, Satoshi Nishiwaki2 (1.Dept. Hematology Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 2.Dept. Hematol&Oncol, Nagoya Univ., Nagoya, Japan)
Shinya Fujita, Akiko Konishi, Hideaki Yoshimura, Masaaki Hotta, Takahisa Nakanishi, Aya Nakaya, Atsushi Satake, Yoshiko Azuma, Yukie Tsubokura, Tomoki Ito, Kazuyoshi Ishii, Shosaku Nomura (Division of Hematology, Kansai Medical University Hospital, Osaka, Japan)
Masayuki Shiseki, Kentaro Yoshinaga, Midori Ishiyama, Aya Watanabe, Yuki Iizuka, Norina Tanaka, Akihito Shinohara, Hiroshi Kazama, Shotaro Hagiwara, Naoki Mori, Junji Tanaka (Depratment of Hematology, Tokyo Women's Medical University)
Hitoshi Yoshida1, Hiroaki Masaie1, Shigeo Fuji1, Yuma Tada1, Midori Koike1, Keiichi Nakata1, Shuhei Kida1, Kazuhito Tsutsumi1, Ryo Nakata1, Manabu Kawakami2, Hiroyuki Sugahara3, Hirokazu Ikeda4, Masashi Nakagawa5, Tsuyoshi Kamae6, Hideki Mitsui6, Jun Ishikawa1 (1.Department of Hematology, Osaka International Cancer Institute, 2.Nissei Hospital, Osaka, Japan, 3.Sumitomo Hospital, Osaka, Japan, 4.National Hospital Organization Osaka National Hospital, Osaka, Japan, 5.Osaka General Medical Center, Osaka, Japan, 6.Otemae Hospital, Osaka, Japan)